Position in VCEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$59,671,944
+$19,303,034 QoQ
Shares Held
1,341,244
+6.9% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 317 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. VCEL ranks #72 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in VCEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,671,944 | 1,341,244 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $40,368,910 | 1,254,862 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,013,690 | 1,222,263 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $38,238,126 | 1,215,066 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $52,778,551 | 1,240,389 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $53,614,945 | 1,201,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $64,031,374 | 1,166,115 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $48,758,739 | 1,154,053 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $52,506,906 | 1,144,440 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $55,346,418 | 1,063,945 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $36,584,966 | 1,027,379 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $32,756,347 | 977,218 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,449,248 | 943,552 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,382,077 | 899,798 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $22,740,085 | 863,329 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,323,929 | 832,928 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,639,945 | 819,696 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $31,771,483 | 831,279 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,871,278 | 810,974 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $39,082,260 | 800,866 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $41,884,920 | 797,808 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $42,140,174 | 758,599 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $21,003,618 | 680,169 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,385,025 | 668,377 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $9,421,826 | 681,753 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $6,089,861 | 664,107 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||